Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7174663 | 0.94 | ALDH1A1 (0.33) | TSHRPOLBMAPK1ALDH1A1GAA | |
| SCHEMBL1326038 | 0.89 | TSHR (0.38) | TSHRPOLBMAPK1ALDH1A1GAA | |
| SCHEMBL2321591 | 0.88 | SNCA (0.42) | TSHRPOLBMAPK1ALDH1A1CYP3A4 | |
| SCHEMBL3290514 | 0.85 | EPHX1 (0.44) | TSHRPOLBMAPK1ALDH1A1GAA | |
| SCHEMBL1326039 | 0.81 | PEPD (0.36) | TSHRPOLBMAPK1ALDH1A1GAA | |
| SCHEMBL233752 | 0.80 | PPM1B (0.44) | ALDH1A1EPHX1CYP3A4TP53 | |
| SCHEMBL987648 | 0.79 | CYP3A4 (0.48) | TSHRPOLBMAPK1ALDH1A1GAA | |
| SCHEMBL423861 | 0.78 | TSHR (0.38) | TSHRPOLBMAPK1ALDH1A1GAA | |
| SCHEMBL4799127 | 0.78 | POLB (0.40) | TSHRPOLBMAPK1ALDH1A1GAA | |
| SCHEMBL1195396 | 0.78 | PPM1B (0.46) | ALDH1A1EPHX1CYP3A4TP53NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3674329-B1 | PHOTOCURABLE RESIN COMPOSITION, INK, AND PAINT | OSAKA SODA CO LTD (JP) | 2024-07-17 | — | — | EP | disclosed |
| US-20230312949-A1 | ACTIVE ENERGY RAY-CURABLE INK COMPOSITION | OSAKA SODA CO., LTD. (JP) | 2023-10-05 | — | — | US | disclosed |
| EP-4130172-A1 | ACTIVE ENERGY RAY-CURABLE INK COMPOSITION | Osaka Soda Co., Ltd. (JP) | 2023-02-08 | — | — | EP | disclosed |
| CN-115244146-A | Active energy ray-curable ink composition | 株式会社大阪曹达 | 2022-10-25 | — | — | CN | disclosed |
| EP-4026857-A1 | PHOTOCURABLE RESIN COMPOSITION, INK AND PAINT | Osaka Soda Co., Ltd. (JP) | 2022-07-13 | — | — | EP | disclosed |
| CN-110997732-B | Photocurable resin composition, ink, and coating material | 株式会社大阪曹达 | 2022-04-15 | — | — | CN | disclosed |
| CN-113165257-A | Apparatus for producing cured resin film and method for producing cured resin film | 昭和电工株式会社 | 2021-07-23 | — | — | CN | disclosed |
| CN-108699314-B | Photocurable resin composition, ink, and coating material | 株式会社大阪曹达 | 2021-07-06 | — | — | CN | disclosed |
| WO-2021044729-A1 | PHOTOCURABLE RESIN COMPOSITION, INK AND PAINT | 株式会社大阪ソーダ | 2021-03-11 | — | — | WO | disclosed |
| US-10941232-B2 | Photocurable resin composition, ink and coating material | OSAKA SODA CO., LTD. (JP) | 2021-03-09 | — | — | US | disclosed |
| US-20180186064-A1 | COMPOSITION FOR LINING | OSAKA SODA CO., LTD. (JP) | 2018-07-05 | — | — | US | disclosed |
| EP-3326784-A1 | COMPOSITION FOR LINING | Osaka Soda Co., Ltd. (JP) | 2018-05-30 | — | — | EP | disclosed |
| US-20170313796-A1 | PHOTOCURABLE RESIN COMPOSITION, INK, AND COATING | OSAKA SODA CO., LTD. (JP) | 2017-11-02 | — | — | US | disclosed |
| EP-3211015-A1 | PHOTOCURABLE RESIN COMPOSITION, INK, AND COATING | Osaka Soda Co., Ltd. (JP) | 2017-08-30 | — | — | EP | disclosed |
| EP-2531496-B1 | MANUFACTURE OF AN EPOXYETHYL CARBOXYLATE OR GLYCIDYL CARBOXYLATE | HEXION RES BELGIUM SA (BE) | 2017-03-15 | — | — | EP | disclosed |
| US-9174955-B2 | Manufacture of an epoxyethyl carboxylate or glycidyl carboxylate | HEXION INC. (US) | 2015-11-03 | — | — | US | disclosed |
| US-9174955-B2 | Manufacture of an epoxyethyl carboxylate or glycidyl carboxylate | HEXION INC. (US) | 2015-11-03 | — | — | US | disclosed |
| US-20130006001-A1 | MANUFACTURE OF AN EPOXYETHYL CARBOXYLATE OR GLYCIDYL CARBOXYLATE | MOMENTIVE SPECIALTY CHEMICALS INC. | 2013-01-03 | — | — | US | disclosed |
| US-20130006001-A1 | MANUFACTURE OF AN EPOXYETHYL CARBOXYLATE OR GLYCIDYL CARBOXYLATE | MOMENTIVE SPECIALTY CHEMICALS INC. | 2013-01-03 | — | — | US | disclosed |
| WO-2011095294-A1 | MANUFACTURE OF AN EPOXYETHYL CARBOXYLATE OR GLYCIDYL CARBOXYLATE | MOMENTIVE SPECIALTY CHEMICALS RESEARCH S.A. (BE) | 2011-08-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130006001-A1 | MANUFACTURE OF AN EPOXYETHYL CARBOXYLATE OR GLYCIDYL CARBOXYLATE | LOX, MLX, TET2 | TSHR 4373/4885POLB 1550/4885MAPK1 3342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.